UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Isolation and Detection of Extended Spectrum β-Lactamase (ESBL)-Producing Enterobacteriaceae from Meat using Chromogenic Agars and Isothermal Loop-Mediated Amplification (LAMP) Assays

Journal of food science, 2013-12, Vol.78 (12), p.M1892-M1898

2013

Volltextzugriff (PDF)

Montezuma Quail (Cyrtonyx montezumae) foraging in a pinyon-juniper woodland

The Wilson journal of ornithology, 2021-12, Vol.133 (4)

2021

Volltextzugriff (PDF)

PCN176 A Multinational Comparison of HTA Decisions for New Treatment Options in Oncology in 2020

Value in health, 2021-06, Vol.24, p.S52-S52

2021

Volltextzugriff (PDF)

Development and initial validation of an instrument to measure physicians' use of, knowledge about, and attitudes toward computers

Journal of the American Medical Informatics Association : JAMIA, 1998-03, Vol.5 (2), p.164-176

1998

Volltextzugriff (PDF)

PND53 - Availability of Real-World Evidence (RWE) to Support Economic Modelling in Primary Progressive Multiple Sclerosis (PPMS)

Value in health, 2018-05, Vol.21, p.S210-S210

2018

Volltextzugriff (PDF)

Availability of Real-World Evidence (RWE) to Support Economic Modelling in Primary Progressive Multiple Sclerosis (PPMS)

Value in health, 2018-05, Vol.21, p.S210

2018

Volltextzugriff (PDF)

A Review of Health Technology Assessments (HTA) of PCSK9 Inhibitors (PSCK9I)

Value in health, 2018-05, Vol.21, p.S68

2018

Volltextzugriff (PDF)

PCV90 - A Review of Health Technology Assessments (HTA) of PCSK9 Inhibitors (PSCK9I)

Value in health, 2018-05, Vol.21, p.S68-S68

2018

Volltextzugriff (PDF)

PNS275 SHOULD LIFECYCLE PRICING BE CONSIDERED IN HTA? PRACTICAL CONSIDERATIONS FOR INCORPORATION INTO HTA POLICY

Value in health, 2019-11, Vol.22, p.S809-S809

2019

Volltextzugriff (PDF)

PNS267 MODELLING OF LIFECYCLE PRICING IN HTA: METHODOLOGICAL CONSIDERATIONS

Value in health, 2019-11, Vol.22, p.S807-S807

2019

Volltextzugriff (PDF)

PCN227 A COMPARISON BETWEEN ICER (US) AND NICE (UK) HEALTH TECHNOLOGY ASSESSMENT (HTA) DECISION-MAKING FOR PD-1 INHIBITORS IN NON-SMALL-CELL LUNG CARCINOMA (NSCLC): OTHER BENEFITS AND CONTEXTUAL CONSIDERATIONS

Value in health, 2019-05, Vol.22, p.S99-S99

2019

Volltextzugriff (PDF)

PCN169 A Retrospective Review of HTA Outcomes for Oncology Treatments Assessed in France and Germany from 2018 to 2020

Value in health, 2021-06, Vol.24, p.S51-S51

2021

Volltextzugriff (PDF)

PRM13 - Analysis of the Asco Value Framework Net Health Benefit Score as A Tool for Assessing Novel Therapies in Relapsed/Refractory Multiple Myeloma (Rrmm)

Value in health, 2016-11, Vol.19 (7), p.A359-A359

2016

Volltextzugriff (PDF)

Analysis of the Asco Value Framework Net Health Benefit Score as A Tool for Assessing Novel Therapies in Relapsed/Refractory Multiple Myeloma (Rrmm )

Value in health, 2016-11, Vol.19 (7), p.A359-A359

2016

Volltextzugriff (PDF)

PHP296 - MANAGED ACCESS AGREEMENTS (MAAS) AND CONTINUING DATA COLLECTION AFTER PROVISIONAL POSITIVE RECOMMENDATION FROM THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)

Value in health, 2018-10, Vol.21, p.S200-S201

2018

Volltextzugriff (PDF)

PHP279 - ASSESSMENT OF THE NICE FAST-TRACK APPRAISAL (FTA) PROCESS

Value in health, 2018-10, Vol.21, p.S197-S197

2018

Volltextzugriff (PDF)

PCN256 Health Technology Assessment for Chimeric Antigen Receptor (CAR) T-CELL Therapies for Cancer in Europe, US, and Canada

Value in health, 2020-12, Vol.23, p.S468-S468

2020

Volltextzugriff (PDF)

PND52 - Health Technology Assessment of Gene Therapies for Inherited Genetic Disorders in the US and Europe

Value in health, 2018-05, Vol.21, p.S210-S210

2018

Volltextzugriff (PDF)

Health Technology Assessment of Gene Therapies for Inherited Genetic Disorders in the US and Europe

Value in health, 2018-05, Vol.21, p.S210

2018

Volltextzugriff (PDF)

PHP261 - Assessment of Public Opinion Regarding The Ethics of Nice CDF, HST, and End-of-Life Criteria for Drug Reimbursement

Value in health, 2017-10, Vol.20 (9), p.A697-A697

2017

Volltextzugriff (PDF)

PSY143 - A Comparison of The Nice Highly Specialised Technology (HST) Programme with Assessment By The National Authority For Health (HAS; France), And The Federal Joint Committee (G-BA; Germany)

Value in health, 2017-10, Vol.20 (9), p.A569-A570

2017

Volltextzugriff (PDF)

Assessment of Public Opinion Regarding The Ethics of Nice CDF, HST, and End-of-Life Criteria for Drug Reimbursement

Value in health, 2017-10, Vol.20 (9), p.A697

2017

Volltextzugriff (PDF)

A Comparison of The Nice Highly Specialised Technology (HST) Programme with Assessment By The National Authority For Health (HAS; France), And The Federal Joint Committee (G-BA; Germany)

Value in health, 2017-10, Vol.20 (9), p.A569-A570

2017

Volltextzugriff (PDF)

EE265 Focal Segmental Glomerulosclerosis (FSGS) in Adults: A Retrospective Analysis of US Prevalence and Impacts of Proteinuria and Kidney Function Decline on Healthcare Resource Utilization (HRU) and Costs

Value in health, 2022-07, Vol.25 (7), p.S385-S386

2022

Volltextzugriff (PDF)

EE369 IgA Nephropathy (IGAN) in Adults: A Retrospective Analysis of US Prevalence and Impacts of Proteinuria and Kidney Function Decline on Healthcare Resource Utilization (HRU) and Costs

Value in health, 2022-07, Vol.25 (7), p.S407

2022

Volltextzugriff (PDF)

1 – 25 von 819

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(674)
Mit Volltextzugriff
(677)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(467)
Life Sciences & Biomedicine
(320)
Biological And Medical Sciences
(165)
Humans
(160)
Animals
(136)
Physical Sciences
(128)
Female
(91)
Fundamental And Applied Biological Sciences. Psychology
(91)
Male
(82)
Physics
(81)
Medical Sciences
(80)
Dermatology
(63)
Adult
(53)
Neurosciences & Neurology
(49)
Neurosciences
(48)
Chemistry
(42)
Technology
(41)
Exact Sciences And Technology
(38)
Middle Aged
(33)
Astronomy & Astrophysics
(32)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(346)
Ingenta
(325)
Journals@Ovid
(287)
MEDLINE
(270)
Wiley Online Library Journals
(197)
NUS Single-Journal Subscriptions
(189)
Access via ScienceDirect (Elsevier)
(172)
Wiley Online Library
(137)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(119)
Access via Oxford University Press
(105)
IngentaConnect Journals
(81)
APS: American Physical Society E-Journals (Physics)
(71)
PROLA - Physical Review Online Archive
(71)
Springer journals
(52)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(45)
Oxford Journals 2020 Medicine
(33)
JSTOR
(33)
IEEE Xplore
(30)
Nexis Uni
(17)
Nature
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Isolation and Detection of Extended Spectrum β-Lactamase (ESBL)-Producing Enterobacteriaceae from Meat using Chromogenic Agars and Isothermal Loop-Mediated Amplification (LAMP) Assays

Montezuma Quail (Cyrtonyx montezumae) foraging in a pinyon-juniper woodland

PCN176 A Multinational Comparison of HTA Decisions for New Treatment Options in Oncology in 2020

Development and initial validation of an instrument to measure physicians' use of, knowledge about, and attitudes toward computers

PND53 - Availability of Real-World Evidence (RWE) to Support Economic Modelling in Primary Progressive Multiple Sclerosis (PPMS)

Availability of Real-World Evidence (RWE) to Support Economic Modelling in Primary Progressive Multiple Sclerosis (PPMS)

A Review of Health Technology Assessments (HTA) of PCSK9 Inhibitors (PSCK9I)

PCV90 - A Review of Health Technology Assessments (HTA) of PCSK9 Inhibitors (PSCK9I)

PNS275 SHOULD LIFECYCLE PRICING BE CONSIDERED IN HTA? PRACTICAL CONSIDERATIONS FOR INCORPORATION INTO HTA POLICY

PNS267 MODELLING OF LIFECYCLE PRICING IN HTA: METHODOLOGICAL CONSIDERATIONS

PCN227 A COMPARISON BETWEEN ICER (US) AND NICE (UK) HEALTH TECHNOLOGY ASSESSMENT (HTA) DECISION-MAKING FOR PD-1 INHIBITORS IN NON-SMALL-CELL LUNG CARCINOMA (NSCLC): OTHER BENEFITS AND CONTEXTUAL CONSIDERATIONS

PCN169 A Retrospective Review of HTA Outcomes for Oncology Treatments Assessed in France and Germany from 2018 to 2020

PRM13 - Analysis of the Asco Value Framework Net Health Benefit Score as A Tool for Assessing Novel Therapies in Relapsed/Refractory Multiple Myeloma (Rrmm)

Analysis of the Asco Value Framework Net Health Benefit Score as A Tool for Assessing Novel Therapies in Relapsed/Refractory Multiple Myeloma (Rrmm )

PHP296 - MANAGED ACCESS AGREEMENTS (MAAS) AND CONTINUING DATA COLLECTION AFTER PROVISIONAL POSITIVE RECOMMENDATION FROM THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)

PHP279 - ASSESSMENT OF THE NICE FAST-TRACK APPRAISAL (FTA) PROCESS

PCN256 Health Technology Assessment for Chimeric Antigen Receptor (CAR) T-CELL Therapies for Cancer in Europe, US, and Canada

PND52 - Health Technology Assessment of Gene Therapies for Inherited Genetic Disorders in the US and Europe

Health Technology Assessment of Gene Therapies for Inherited Genetic Disorders in the US and Europe

PHP261 - Assessment of Public Opinion Regarding The Ethics of Nice CDF, HST, and End-of-Life Criteria for Drug Reimbursement

PSY143 - A Comparison of The Nice Highly Specialised Technology (HST) Programme with Assessment By The National Authority For Health (HAS; France), And The Federal Joint Committee (G-BA; Germany)

Assessment of Public Opinion Regarding The Ethics of Nice CDF, HST, and End-of-Life Criteria for Drug Reimbursement

A Comparison of The Nice Highly Specialised Technology (HST) Programme with Assessment By The National Authority For Health (HAS; France), And The Federal Joint Committee (G-BA; Germany)

EE265 Focal Segmental Glomerulosclerosis (FSGS) in Adults: A Retrospective Analysis of US Prevalence and Impacts of Proteinuria and Kidney Function Decline on Healthcare Resource Utilization (HRU) and Costs

EE369 IgA Nephropathy (IGAN) in Adults: A Retrospective Analysis of US Prevalence and Impacts of Proteinuria and Kidney Function Decline on Healthcare Resource Utilization (HRU) and Costs

Suchergebnisse filtern